Title: Kinmei Leung - Innovator in Cancer Biomarkers
Introduction
Kinmei Leung is an inventor based in Cambridge, GB. He has made significant contributions to the field of biotechnology, particularly in the area of cancer biomarkers. Although he currently holds no granted patents, his work is noteworthy for its potential impact on cancer treatment.
Latest Patent Applications
Kinmei Leung's latest patent application is titled "Cancer Biomarkers and Uses Thereof." This invention relates to the use of Human Epidermal Growth Factor Receptor 2 (HER2) gene copy number and HER2 mRNA levels as biomarkers. These biomarkers are intended to identify cancers that will respond to treatment with a specific binding member. This member comprises a HER2 antigen binding site engineered into a structural loop region of a constant domain, such as the CH3 domain, and specific binding members that compete for binding to HER2.
Conclusion
Kinmei Leung's innovative work in cancer biomarkers highlights the importance of research in biotechnology. His contributions may pave the way for advancements in cancer treatment and patient care.